Texture-Modified Soy Protein Gels Using Transglutaminase and Agar for Elderly Dysphagia Management

吞咽困难 吞咽 大豆蛋白 组织谷氨酰胺转胺酶 食品科学 琼脂 感官的 医学 化学 牙科 生物 外科 生物化学 遗传学 细菌
作者
Puchcharin Paleekui,Benjamard Rattanamato,Nattapong Kanha,Kanyasiri Rakariyatham,Wannaporn Klangpetch,Sukhuntha Osiriphun,Thunnop Laokuldilok
出处
期刊:Gels [Multidisciplinary Digital Publishing Institute]
卷期号:11 (4): 303-303 被引量:2
标识
DOI:10.3390/gels11040303
摘要

Dysphagia, a condition characterized by difficulty swallowing, is commonly found in the elderly, increasing the risk of choking and aspiration. This study aimed to develop a texturally modified soy protein gel that meets the Universal Design Food (UDF) standard, specifically for elderly individuals with dysphagia. To create soft-textured foods, the gel’s texture was modified using transglutaminase at varying concentrations (0.5%, 1.0%, and 2.0%, w/v) in combination with agar. The soy protein gel prepared with 0.5% transglutaminase exhibited the lowest hardness value (2.2 × 103 N/m2) and was classified as Level 4 under the UDF standard, indicating that it requires no chewing and is easy to swallow, making it suitable for individuals with severe dysphagia. In contrast, the gel formulated with 2.0% transglutaminase and 0.5% agar had the highest hardness value (3.29 × 104 N/m2) and was classified as Level 2, meaning it can be easily mashed with the gums, making it appropriate for individuals with moderate dysphagia. Structural analyses revealed that modifying with transglutaminase altered the protein’s secondary structure by reducing the content of α-helixes and β-sheets while increasing β-turns, potentially enhancing gel network flexibility. These findings suggest that the combined use of transglutaminase and agar effectively modifies soy protein gel texture to meet the dietary needs of elderly individuals with dysphagia. This approach shows promise for the food industry by providing safer and more diverse food options for aging populations facing dysphagia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
宇宙帅船完成签到,获得积分10
刚刚
1秒前
枭源完成签到,获得积分10
1秒前
Jasper应助陈帅采纳,获得10
1秒前
1秒前
duoduo完成签到,获得积分10
2秒前
2秒前
完美世界应助wangyan采纳,获得10
2秒前
txixi发布了新的文献求助10
3秒前
Sledge发布了新的文献求助10
3秒前
ccy完成签到,获得积分10
3秒前
CipherSage应助11采纳,获得10
4秒前
4秒前
法就发布了新的文献求助50
4秒前
木光完成签到,获得积分10
4秒前
陈飞宇完成签到,获得积分10
4秒前
shenl完成签到,获得积分10
4秒前
新能源完成签到,获得积分10
4秒前
古月完成签到 ,获得积分10
5秒前
5秒前
酒温书生发布了新的文献求助10
5秒前
果酱的奥特曼完成签到,获得积分10
6秒前
XMC2022完成签到,获得积分10
6秒前
念姬完成签到,获得积分10
6秒前
魔幻高烽发布了新的文献求助10
7秒前
7秒前
hygogogo发布了新的文献求助10
7秒前
minever白完成签到,获得积分10
7秒前
shilong.yang完成签到,获得积分10
7秒前
Kao应助去码头整点薯条采纳,获得10
7秒前
1433223完成签到,获得积分10
7秒前
yxf完成签到,获得积分10
8秒前
阳光宝贝发布了新的文献求助10
8秒前
9秒前
星辰大海应助27采纳,获得10
9秒前
9秒前
9秒前
9秒前
Sledge完成签到,获得积分10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6952833
求助须知:如何正确求助?哪些是违规求助? 8636832
关于积分的说明 18314365
捐赠科研通 6396113
什么是DOI,文献DOI怎么找? 3082545
关于科研通互助平台的介绍 2128236
邀请新用户注册赠送积分活动 2059406